Depression

Medically Reviewed by Mark Hrymoc, M.D., Chief Medical Officer, double-board certified in General & Addiction Psychiatry Depression is one of the most treatable mental health conditions, yet for many people, traditional therapies like antidepressants and talk therapy are not enough to achieve lasting relief. When symptoms persist despite multiple treatment attempts, this is referred to as treatment-resistant depression (TRD). The experience can be deeply discouraging, leaving patients feeling hopeless or misunderstood. However, TRD does not mean untreatable. Advances in psychiatric care now offer several promising options for those whose depression has not responded to conventional approaches. Understanding Treatment-Resistant Depression Clinicians typically define treatment-resistant depression as a major depressive episode that does not adequately improve after at least two trials of antidepressant medication at therapeutic doses and durations. According to estimates from the National Institute of Mental Health, roughly 30% of people with depression meet this definition. TRD can be partial—where …

Read more

Medically Reviewed by Mark Hrymoc, M.D., Chief Medical Officer, double-board certified in General & Addiction Psychiatry When someone you love is struggling with depression, it can be difficult to know how to help. Feelings of helplessness, frustration, and worry are common among partners. Supporting a loved one through depression requires empathy, communication, and patience—along with awareness of your own emotional limits. Understanding Depression Depression is a complex mood disorder that affects both emotional and physical health. Symptoms may include sadness, fatigue, loss of interest, irritability, and difficulty concentrating. Recognizing that depression is a medical condition, not a personal weakness, helps remove blame and fosters compassion. How to Communicate Supportively Open communication is essential. Use statements like “I’m here for you” instead of trying to fix the problem. Listening without judgment encourages trust and allows your partner to express emotions freely. Avoid minimizing their experiences or offering overly simple solutions. Encouraging …

Read more

Medically Reviewed by Mark Hrymoc, M.D., Chief Medical Officer, double-board certified in General & Addiction Psychiatry Suicidal ideation in major depressive disorder and bipolar depression remains a public health emergency, with U.S. deaths by suicide reaching historically high levels in recent years. Against this backdrop, NRx Pharmaceuticals has advanced two investigational agents that target this gap: NRX-100, a preservative-free intravenous ketamine, and NRX-101, an oral fixed-dose combination of D-cycloserine and lurasidone. Understanding how FDA pathways such as Fast Track and Accelerated Approval work, and where these programs may apply, helps clarify what patients, families, and clinicians might expect as development moves forward. Where NRX-100 and NRX-101 Fit Clinically NRX-100 is being studied for rapid relief of acute suicidal ideation in depression, including bipolar depression. Ketamine’s rapid antidepressant effect is well documented, but its clinical use has been limited by temporary benefit and the need for monitored infusion. A proprietary, preservative-free …

Read more